New blood test offers early detection of drug-induced tissue damage in cancer patients
A team of researchers have applied a novel blood test that can detect early signs of potentially fatal lung damage in cancer ...
Pharmabiz11h
AstraZeneca, Daiichi Sankyo seek US FDA’s accelerated approval for datopotamab deruxtecan to treat advanced EGFR-mutated NSCLC
AstraZeneca, Daiichi Sankyo seek US FDA’s accelerated approval for datopotamab deruxtecan to treat advanced EGFR-mutated NSCLC ...
News Medical on MSN20h
New blood test detects early lung damage in cancer patients on targeted therapy
New study introduces a simple blood test to detect early lung damage in cancer patients receiving novel therapy with antibody ...
precisionmedicineonline20h
AstraZeneca Reports Q2 Revenue Growth for Precision Cancer Drugs Amid Ongoing China Investigations
One investigation discussed during the call involves sales reps in China allegedly changing genetic testing results to secure reimbursement for Tagrisso.